T1	Participants 636 894	Parents of 101 children with autism who had participated in a multi-site 8-week double-blind clinical trial of risperidone were given a questionnaire at the end to elicit their perceptions of the appropriateness and acceptability of clinical trial procedures
T2	Participants 904 957	Ninety-six (95.0%) parents returned the questionnaire
T3	Participants 969 1148	80.0 to 96.8%, depending on the question, expressed satisfaction with their child's research participation regardless of treatment outcome or assignment to active drug or placebo.
T4	Participants 1157 1281	90.5% of parents indicated that they would "definitely" recommend the clinical trial to other families with similar children
T5	Participants 1294 1309	92.7% indicated
